Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2021 | 3 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study.
Lancet Oncol. 2021 Jul;22(7):1034-1046. doi: 10.1016/S1470-2045(21)00216-3. Epub 2021 Jun 15.
Lancet Oncol. 2021.
PMID: 34143970
Clinical Trial.
Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial.
Monk BJ, Colombo N, Oza AM, Fujiwara K, Birrer MJ, Randall L, Poddubskaya EV, Scambia G, Shparyk YV, Lim MC, Bhoola SM, Sohn J, Yonemori K, Stewart RA, Zhang X, Perkins Smith J, Linn C, Ledermann JA.
Monk BJ, et al. Among authors: stewart ra.
Lancet Oncol. 2021 Sep;22(9):1275-1289. doi: 10.1016/S1470-2045(21)00342-9. Epub 2021 Aug 4.
Lancet Oncol. 2021.
PMID: 34363762
Clinical Trial.
Item in Clipboard
Development of PARP and Immune-Checkpoint Inhibitor Combinations.
Stewart RA, Pilié PG, Yap TA.
Stewart RA, et al.
Cancer Res. 2018 Dec 15;78(24):6717-6725. doi: 10.1158/0008-5472.CAN-18-2652. Epub 2018 Nov 29.
Cancer Res. 2018.
PMID: 30498083
Review.
Item in Clipboard
Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancer.
Schofield DJ, Percival-Alwyn J, Rytelewski M, Hood J, Rothstein R, Wetzel L, McGlinchey K, Adjei G, Watkins A, Machiesky L, Chen W, Andrews J, Groves M, Morrow M, Stewart RA, Leinster A, Wilkinson RW, Hammond SA, Luheshi N, Dobson C, Oberst M.
Schofield DJ, et al. Among authors: stewart ra.
MAbs. 2021 Jan-Dec;13(1):1857100. doi: 10.1080/19420862.2020.1857100.
MAbs. 2021.
PMID: 33397194
Free PMC article.
Item in Clipboard
IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells.
Camelo A, Rosignoli G, Ohne Y, Stewart RA, Overed-Sayer C, Sleeman MA, May RD.
Camelo A, et al. Among authors: stewart ra.
Blood Adv. 2017 Mar 30;1(10):577-589. doi: 10.1182/bloodadvances.2016002352. eCollection 2017 Apr 11.
Blood Adv. 2017.
PMID: 29296700
Free PMC article.
Item in Clipboard
Cite
Cite